Mark A. Popovsky

发表

Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion‐associated circulatory overload have proinflammatory aspects?

J. Steingrub, P. Visintainer, M. Popovsky, 2012, Transfusion.

Transfusion‐associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus

G. Illei, J. Tisdale, D. Boumpas, 2003, Transfusion.

Anemia, iron depletion, and the blood donor: it's time to work on the donor's behalf

M. Popovsky, Mark A. Popovsky, 2012, Transfusion.

Vasovagal donor reactions: An important issue with implications for the blood supply

M. Popovsky, Mark A. Popovsky, 2002, Transfusion.

Extended storage of AS‐1 and AS‐3 leukoreduced red blood cells for 15 days after deglycerolization and resuspension in AS‐3 using an automated closed system

N. Bandarenko, M. Popovsky, P. Whitley, 2004, Transfusion.

Transfusion‐associated adverse pulmonary sequelae: widening our perspective

C. Andrzejewski, Mark A. Popovsky, 2005, Transfusion.

Autologous transfusion in Jehovah's Witnesses

S. Moore, Mark A. Popovsky, 1985, Transfusion.

Transfusion‐associated circulatory overload: the plot thickens

M. Popovsky, Mark A. Popovsky, 2009, Transfusion.

Controversies in transfusion medicine: is autologous blood transfusion worth the cost? Pro

M. Popovsky, Mark A. Popovsky, 1994, Transfusion.